Accéder au contenu
Merck

Effect of indomethacin and lactoferrin on human tenocyte proliferation and collagen formation in vitro.

Biochemical and biophysical research communications (2014-12-03)
Yaonan Zhang, Xiao Wang, Yiwei Qiu, Jillian Cornish, Andrew J Carr, Zhidao Xia
RÉSUMÉ

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in patients with injuries and inflammation of tendon and ligament, and as post-surgical analgesics. The aim of this study is to investigate the effect of indomethacin, a classic NSAID and its combinational effect with an anabolic agent of skeletal tissue, lactoferrin, on the proliferation and collagen formation of human tenocytes in vitro. A factorial experimental design was employed to study the dose-dependent effect of the combination of indomethacin and lactoferrin. The results showed that indomethacin at high concentration (100 μM) inhibited human tenocyte proliferation in culture medium with 1-10% fetal bovine serum (FBS) in vitro. Also, high dose of indomethacin inhibited the collagen formation of human tenocytes in 1% FBS culture medium. Lactoferrin at 50-100 μg/ml promoted human tenocyte survival in serum-free culture medium and enhanced proliferation and collagen synthesis of human tenocytes in 1% FBS culture medium. When 50-100 μg/ml lactoferrin was used in combination with 100-200 μM indomethacin, it partially rescued the inhibitory effects of indomethacin on human tenocyte proliferation, viability and collagen formation. To our knowledge, it is the first evidence that lactoferrin is anabolic to human tenocytes in vitro and reverses potential inhibitory effects of NSAIDs on human tenocytes.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Hydroxyde de sodium, ACS reagent, ≥97.0%, pellets
Sigma-Aldrich
Hydroxyde de sodium, reagent grade, ≥98%, pellets (anhydrous)
Sigma-Aldrich
Hydroxyde de sodium solution, 50% in H2O
Sigma-Aldrich
Hydroxyde de sodium solution, BioUltra, for molecular biology, 10 M in H2O
Sigma-Aldrich
Hydroxyde de sodium, BioXtra, ≥98% (acidimetric), pellets (anhydrous)
Sigma-Aldrich
Hydroxyde de sodium solution, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Hydroxyde de sodium, puriss. p.a., ACS reagent, reag. Ph. Eur., K ≤0.02%, ≥98%, pellets
Sigma-Aldrich
Hydroxyde de sodium, puriss., meets analytical specification of Ph. Eur., BP, NF, E524, 98-100.5%, pellets
Sigma-Aldrich
Hydroxyde de sodium, reagent grade, 97%, powder
Sigma-Aldrich
Hydroxyde de sodium, pellets, semiconductor grade, 99.99% trace metals basis
Sigma-Aldrich
Hydroxyde de sodium solution, 5.0 M
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
Hydroxyde de sodium, puriss. p.a., ACS reagent, K ≤0.02%, ≥98.0% (T), pellets
Sigma-Aldrich
Hydroxyde de sodium, beads, 16-60 mesh, reagent grade, 97%
Sigma-Aldrich
Hydroxyde de sodium, reagent grade, 97%, flakes
Sigma-Aldrich
Hydroxyde de sodium, BioUltra, for luminescence, ≥98.0% (T), pellets
Supelco
Hydroxyde de sodium solution, 0.1 M NaOH in water (0.1N), Eluent concentrate for IC
Sigma-Aldrich
Hydroxyde de sodium solution, purum, ≥32%
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Supelco
Hydroxyde de sodium solution, 49-51% in water, eluent for IC
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Sodium hydroxide-16O solution, 20 wt. % in H216O, 99.9 atom % 16O
USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
3-Ethyl-2,4-pentanedione, mixture of tautomers, 98%
Sigma-Aldrich
Hydroxyde de sodium, anhydrous, free-flowing, Redi-Dri, reagent grade, ≥98%, pellets
Indomethacin, European Pharmacopoeia (EP) Reference Standard